Comerica Bank’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-503
| Closed | -$2.41K | – | 3768 |
|
2024
Q4 | $2.41K | Sell |
503
-504
| -50% | -$2.41K | ﹤0.01% | 3454 |
|
2024
Q3 | $4.72K | Hold |
1,007
| – | – | ﹤0.01% | 3348 |
|
2024
Q2 | $5.69K | Hold |
1,007
| – | – | ﹤0.01% | 3279 |
|
2024
Q1 | $4.14K | Sell |
1,007
-25
| -2% | -$103 | ﹤0.01% | 3373 |
|
2023
Q4 | $4.36K | Hold |
1,032
| – | – | ﹤0.01% | 3358 |
|
2023
Q3 | $4.46K | Buy |
1,032
+198
| +24% | +$855 | ﹤0.01% | 3391 |
|
2023
Q2 | $75 | Buy |
+834
| New | +$75 | 0.01% | 137 |
|
2022
Q4 | $258K | Sell |
33,847
-9,509
| -22% | -$72.5K | ﹤0.01% | 1997 |
|
2022
Q3 | $450K | Sell |
43,356
-4,715
| -10% | -$48.9K | ﹤0.01% | 1817 |
|
2022
Q2 | $555K | Buy |
48,071
+365
| +0.8% | +$4.21K | ﹤0.01% | 1789 |
|
2022
Q1 | $537K | Buy |
47,706
+1,180
| +3% | +$13.3K | ﹤0.01% | 1841 |
|
2021
Q4 | $682K | Sell |
46,526
-55,941
| -55% | -$820K | 0.01% | 1739 |
|
2021
Q3 | $1.72M | Buy |
102,467
+50,469
| +97% | +$848K | 0.01% | 1396 |
|
2021
Q2 | $798K | Sell |
51,998
-3,400
| -6% | -$52.2K | ﹤0.01% | 1828 |
|
2021
Q1 | $940K | Sell |
55,398
-2,155
| -4% | -$36.6K | 0.01% | 1780 |
|
2020
Q4 | $817K | Buy |
57,553
+497
| +0.9% | +$7.06K | 0.01% | 1824 |
|
2020
Q3 | $585K | Sell |
57,056
-51
| -0.1% | -$523 | ﹤0.01% | 1836 |
|
2020
Q2 | $621K | Buy |
57,107
+5,424
| +10% | +$59K | ﹤0.01% | 1769 |
|
2020
Q1 | $617K | Buy |
51,683
+1,609
| +3% | +$19.2K | 0.01% | 1628 |
|
2019
Q4 | $651K | Buy |
50,074
+65
| +0.1% | +$845 | ﹤0.01% | 1778 |
|
2019
Q3 | $686K | Buy |
50,009
+405
| +0.8% | +$5.56K | 0.01% | 1733 |
|
2019
Q2 | $659K | Sell |
49,604
-2,238
| -4% | -$29.7K | 0.01% | 1753 |
|
2019
Q1 | $928K | Buy |
51,842
+725
| +1% | +$13K | 0.01% | 1617 |
|
2018
Q4 | $1.46M | Buy |
+51,117
| New | +$1.46M | 0.01% | 1315 |
|